Marco Zimarino, Marco Barbanti, George D Dangas, Luca Testa, Davide Capodanno, Giulio G Stefanini, Francesco Radico, Michele Marchioni, Ignacio Amat-Santos, Tommaso Piva, Francesco Saia, Bernhard Reimers, Carlo De Innocentiis, Andrea Picchi, Alessandro Toro, Tania Rodriguez-Gabella, Elisa Nicolini, Carolina Moretti, Sabina Gallina, Nicola Maddestra, Francesco Bedogni, Corrado Tamburino
BACKGROUND: There is no consensus on the benefit of red blood cell (RBC) transfusion after transcatheter aortic valve replacement. METHODS: The multicenter Transfusion Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) registry retrospectively included patients after transfemoral transcatheter aortic valve replacement; propensity score-matching identified pairs of patients with and without RBC transfusion. The primary end point was 30-day mortality; nonfatal myocardial infarction, cerebrovascular accident, and stage 2 to 3 acute kidney injury at 30 days were secondary end points...
December 2020: Circulation. Cardiovascular Interventions